Purchase of a Typhoon Phosphorimager-Fluoroimager for the Keck Biophysics Facilit
为凯克生物物理设施购买一台台风荧光成像仪-荧光成像仪
基本信息
- 批准号:7794543
- 负责人:
- 金额:$ 11.99万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-02-20 至 2011-02-19
- 项目状态:已结题
- 来源:
- 关键词:Alzheimer&aposs DiseaseArtsBiological SciencesBiophysicsBone DiseasesBrainCell divisionChronic Obstructive Airway DiseaseCommunitiesEquipmentEukaryotic CellFundingGelGenomicsHourHuntington DiseaseImageInfertilityInstitutionMalignant NeoplasmsMolecularParkinson DiseasePharmaceutical PreparationsPolycystic Kidney DiseasesResearchResearch PersonnelResearch Project GrantsResource SharingSignal PathwayStructureTechnical ExpertiseTherapeuticUniversitiesbasehuman diseaseinnovationinstrument
项目摘要
DESCRIPTION (provided by applicant): This is a proposal to acquire a state of the art Typhoon Fluoroimager/Phosphoimager as a shared instrument for the Northwestern University research community. This instrument provides versatile imaging capabilities and exceptional sensitivity for characterization of fluorescent and chemifluorescent gels and blots. Such capabilities are required by many NIH-funded projects currently underway at NU (including, but not limited to, the 15 projects described in detail in this application) and are not available at Northwestern or at other nearby academic institutions. The instrument will be integrated in the Keck Biophysics Facility - a well known resource of shared equipment and technical expertise available to NU researchers on a 24 hours a day, 7 days a week basis. The need for the capabilities provided by the Typhoon imager for the NU Life Sciences research community cannot be underscored: about 40 research groups would benefit from such capabilities on a daily basis; research projects include those seeking to understand basic aspects of genomic structure and function, signaling pathways central to eukaryotic cell division and differentiation, or molecular origins of various human diseases (e.g., Huntington's disease, Parkinson's disease, Alzheimer's disease, polycystic kidney disease, chronic obstructive pulmonary disease), as well as those aiming to develop revolutionary drugs and innovative therapeutic strategies for cancer, infertility, and brain and bone disorders.
描述(由申请人提供):这是一项收购最先进的台风荧光成像仪/磷光成像仪的提案,作为西北大学研究社区的共享仪器。该仪器具有多种成像功能和卓越的灵敏度,可用于表征荧光和化学荧光凝胶和斑点。这种能力是NIH资助的许多目前正在南大进行的项目(包括但不限于本申请中详细描述的15个项目)所需的,而西北大学或附近其他学术机构无法提供这种能力。该仪器将被整合到凯克生物物理设施中,这是一个著名的共享设备和技术专长的资源,NU的研究人员一周7天、每天24小时都可以使用。人们对台风成像仪为NU生命科学研究界提供的能力的需求不容忽视:大约40个研究小组每天都将从这种能力中受益;研究项目包括试图了解基因组结构和功能的基本方面、真核细胞分裂和分化的关键信号途径、或各种人类疾病(如亨廷顿病、帕金森病、阿尔茨海默病、多囊肾病、慢性阻塞性肺病)的分子起源,以及旨在针对癌症、不孕症、脑和骨骼疾病开发革命性药物和创新治疗策略的研究项目。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jonathan Widom其他文献
Jonathan Widom的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jonathan Widom', 18)}}的其他基金
The Coding, Decoding, Transfer, and Translation of Information in Cancer
癌症信息的编码、解码、传输和翻译
- 批准号:
8142675 - 财政年份:2009
- 资助金额:
$ 11.99万 - 项目类别:
The Coding, Decoding, Transfer, and Translation of Information in Cancer
癌症信息的编码、解码、传输和翻译
- 批准号:
7942783 - 财政年份:2009
- 资助金额:
$ 11.99万 - 项目类别:
The Coding, Decoding, Transfer, and Translation of Information in Cancer
癌症信息的编码、解码、传输和翻译
- 批准号:
7789035 - 财政年份:2009
- 资助金额:
$ 11.99万 - 项目类别:
Center Organizarion and Infrastructure, Administration
中心组织和基础设施、行政
- 批准号:
7820286 - 财政年份:2009
- 资助金额:
$ 11.99万 - 项目类别:
相似国自然基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
- 批准号:81000622
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
- 批准号:31060293
- 批准年份:2010
- 资助金额:26.0 万元
- 项目类别:地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
- 批准号:30960334
- 批准年份:2009
- 资助金额:22.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
- 批准号:
10657993 - 财政年份:2023
- 资助金额:
$ 11.99万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10381163 - 财政年份:2022
- 资助金额:
$ 11.99万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10531959 - 财政年份:2022
- 资助金额:
$ 11.99万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10700991 - 财政年份:2022
- 资助金额:
$ 11.99万 - 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10518582 - 财政年份:2022
- 资助金额:
$ 11.99万 - 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10672973 - 财政年份:2022
- 资助金额:
$ 11.99万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10585925 - 财政年份:2022
- 资助金额:
$ 11.99万 - 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
- 批准号:
10180000 - 财政年份:2021
- 资助金额:
$ 11.99万 - 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
- 批准号:
10049426 - 财政年份:2021
- 资助金额:
$ 11.99万 - 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
- 批准号:
10295809 - 财政年份:2021
- 资助金额:
$ 11.99万 - 项目类别: